Witold Bachorski

The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept.

M. Jaguszewski, M. Gruchała, G. Zuk, 2016, Cardiology journal.

Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland

G. Raczak, M. Gruchała, A. Kuchta, 2021, Journal of clinical apheresis.

Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis center

G. Raczak, M. Jaguszewski, M. Gruchała, 2019, Cardiology journal.

Vitamin B1 Deficiency and Perimyocarditis Fulminans: A Case Study of Shoshin Syndrome in a Woman Following an Unbalanced Dietary Pattern Followed by a Literature Review

G. Raczak, M. Gruchała, L. Daniłowicz-Szymanowicz, 2023, Life.

New-generation drug eluting stent vs. bare metal stent in saphenous vein graft - 1 year outcomes by a propensity score ascertainment (SVG Baltic Registry).

D. Dudek, M. Chmielecki, M. Jaguszewski, 2019, International journal of cardiology.

The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept.

M. Jaguszewski, M. Gruchała, G. Zuk, 2016, Cardiology journal.